Haute Lumière
Commerce · III.07 · MMXXVI · daylight
For the person with a P&L, a facility agreement, an audit committee and a quarter. This workbook uses the language of the firm without apology, because the firm's own documents already contain most of what follows — they have simply never been arranged to show it.
You hold assets whose productive capacity is rising and whose carrying value is falling, on a schedule, by convention. That is not a philosophical complaint. It is a measurable distortion with three consequences you can act on this quarter:
The work is to bring those three into one document before somebody else brings you the third one.
Exercise 1.1 — The routing sheet (one afternoon with your controller)
Take the fixed asset register and the balance sheet and run every material line through four questions, in order.
| # | Question | If no |
|---|---|---|
| 1 | Does it regenerate without us? | Out of scope. Stop. Most of the register is here. |
| 2 | Can our decisions change the rate? | Disclose the dependency and its trend. Stop. |
| 3 | Observable market for it as it stands today? | Physical schedule only. Money column £0. |
| 4 | Already measured by somebody, for another reason? | You have found your cost problem. |
Output: one page. Every £0 carries a one-sentence justification. That sentence is what survives the challenge; a blank row does not.
Exercise 1.2 — The four documents you already pay for (one week)
Ask for these and read them yourself. Do not delegate this; the value is in seeing them side by side.
Exercise 1.3 — The gap statement (90 minutes)
One page for the audit committee: for each material living stock, the carrying value, the best external market indication, the date of that indication, and its source. No recommendation. No conclusion. The gap is the finding, and a page with no recommendation on it is read more carefully than a page with one.
Exercise 2.1 — Restate one stock, properly (two weeks)
Choose the largest and best-measured. Then, in this order:
Exercise 2.2 — Run the covenant model both ways (one day)
Build the covenant pack on the restated basis and on the filed basis, side by side, for every covenant in the agreement.
interest cover, PBIT basis, >= 2.50 x filed 2.32 x BREACH restated 3.20 x
net debt / EBITDA, <= 4.00 x filed 3.92 x restated 3.92 x
tangible net worth, >= £ 2,000,000 filed £2,990,000 restated £3,378,737
Then run the downside before you run the upside, and present it first. Hold volumes constant — 971 cubic metres grown, 300 removed, 14,835 standing — and move the price to 75 percent. Minus £98,113 through profit and loss, operating profit £334,887, cover 2.36 times against a 2.50 times covenant. A breach caused by a price index, with no cash movement.
Exercise 2.3 — Price the exposure before anybody prices it for you (half a day)
base audit fee £ 42,000
significant-risk Level 3 uplift, 43 % £ 18,060
independent valuations, annual £ 20,000
frozen-GAAP side letter over five years £ 1,600
TOTAL ANNUAL COST £ 39,660
against a 35bp step-down on £2,450,000 £ 8,575
NET £ -31,085 cover 0.22 x
breakeven debt £11,331,429
Put that table in your own paper, on page one. On the financing argument alone, an enterprise below roughly £11.3m of debt should not do this, and saying so is what makes the rest of your paper credible. A proposal that cannot state the size below which it fails has not been costed.
Exercise 2.4 — Find the argument that does pay (one week)
Three counterparties, three mechanisms, and only one of them is the lending argument you started with.
Exercise 3.1 — Write it in this order (one week)
Six sections, and the order is the argument.
Exercise 3.2 — The three conversations, in this sequence (four weeks)
The auditor, first and in writing. Ask about measurement reliability and useful economic life. These are conversations they have every year and are good at. Ask before the year end, not during it, and ask in a meeting you called.
The lender, second. Ask for a frozen-GAAP clause — covenants tested on the accounting basis in force at signing. About £8,000 of legal time and the cheapest protection in this entire subject. Ask for it whether or not you adopt fair value; it costs the lender nothing today and it removes a whole category of future argument.
The audit committee, last. By then you are reporting a position rather than proposing one, and you have the auditor's view and the lender's clause in hand.
Exercise 3.3 — Decide what you will not do (two hours)
Write down, before anybody asks, the three things you are declining:
Declining three things in writing is what makes the fourth thing believable.
Four places, in most firms, and none of them needs a new system.
The fixed asset register. Items at or near zero book value still in production. Each is somebody's judgement that the schedule was wrong, and the register is a list of them.
The disposal gains line. A large gain on disposal is usually a measurement error being paid out in one period. Pull three years and look at the ratio of gain to proceeds.
The security valuation file. Already market, already annual, already signed by somebody with professional indemnity cover.
The insurance schedule. Already restated, already external, already paid for.
You are not asking the firm to believe anything new. You are asking it to put four documents it already commissions on the same page, and to notice that three of them disagree with the fourth in a consistent direction.
Every one of these will be raised, usually in this order, and each has a short answer that is also true. Rehearse them; the paper is won or lost in the eight minutes of questions after it.
"This is aggressive accounting." It is the opposite, and the arithmetic says so. The valuation is struck less costs to sell — £481,576 becomes £457,497 — and the deferred tax is recognised in the same motion. Meanwhile the convention you are being asked to keep recognises a deferred tax liability of £2,160,000 at full undiscounted face on a disposal nobody intends to make, when its present value at the firm's own borrowing cost over the expected holding period is £527,609. One of the two treatments is asymmetric and it is not yours.
"The auditors will never accept it." They have accepted it since 2003. IAS 41 requires fair value less costs to sell for biological assets and puts the change through profit or loss. The question you are actually asking your auditor is a measurement-reliability question and a useful-economic-life question, and those are conversations they have every year. Ask early, in writing, in a meeting you called, and ask before the year end rather than during it.
"It adds volatility we do not need." Correct, and you have already priced it: £39,660 a year of assurance cost, and a downside case in which a 25 percent price fall puts minus £98,113 through profit or loss and takes cover to 2.36 times against a 2.50 times covenant. That is why the frozen-GAAP clause is in the recommendation and why it is asked for first. An enterprise that adopts fair value before it has that clause has bought the downside and not yet bought the defence.
"What problem does this actually solve?" The best question and the one to answer last, because it is the one with a number. The exposure already exists, assessed on market value, while the accounts show cost. On the illustrative farm the charge is £2,491,163 against book equity of £2,990,000 — 83.3 percent — and it arrives as ten instalments of £249,116 covered 1.30 times by cash of £323,000. Nothing in the restatement creates that. The restatement is the document that makes it visible while there is still time to fund it, and the alternative is finding out in the year it falls due.
One tactical note on sequence. Do not lead with the growth. Lead with the gap between the security valuation you already commission and the carrying value you already file — on the illustrative farm, £11,280,000 against £2,640,000, or 4.27 times. That gap is somebody else's number, signed by somebody else, and it puts the whole discussion on ground you did not choose. By the time you reach the growth figures the room has already conceded the principle, because it conceded it years ago when it accepted the valuation.
One. Can you state, from memory, which of your covenants would move under a restatement and which would not — and quote the definition that decides it?
Two. Have you priced the exposure before the benefit, in your own paper, on page one?
Three. Can you name the counterparty for whom this restatement is worth more than it costs, and prove it with a breakeven rather than a projection?
Four. Is there a £0 in your money column that you can defend in one sentence to a hostile reader?
Five. Does your downside case hold volumes constant while moving price — and does your paper present it before the upside?
Six. Have you asked the auditor first, in writing, in a meeting you called?
Six yeses and this is a position, not a proposal. Five and it is a good draft. Fewer, and the missing one is almost always the third, because the lending argument is the one everybody reaches for and it is the one that fails first.
A last note on timing. Start this in the first quarter of a financial year, never the last. The count needs a clean opening position, the auditor needs the conversation before the year end rather than during it, and the lender's appetite for an amendment is highest when nothing is being asked of them urgently. A restatement begun in month eleven becomes a year-end argument, and a year-end argument is the one environment in which every party defaults to the convention they already know.